NOT:ETR
Novartis AG
126,96 €
arrow_upward
+0,59%(+0,74) 1D
25 sht, 10:58:35 p.d., GMT+2 · EUR
search
TĂ« gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOT...
Hap
125,48 €
I lartë
126,96 €
I ulët
125,48 €
Kapitalizimi i tregut
243,77Â mld
VĂ«llimi mesatar
5,94 mijë
VĂ«llimi
320,00
Maksimumi 52-javor
144,12 €
Minimumi 52-javor
103,58 €
Numri i punonjësve
75 mijë
Hap
125,48 €
I lartë
126,96 €
I ulët
125,48 €
Kapitalizimi i tregut
243,77Â mld
VĂ«llimi mesatar
5,94 mijë
VĂ«llimi
320,00
Maksimumi 52-javor
144,12 €
Minimumi 52-javor
103,58 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
16 orë më parë
Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
www.marketscreener.com
·
2 ditë më parë
Europe Is Losing the Pharma Investment Race – But the Comeback Is Within Reach: An open letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi
Reuters
·
1 javë më parë
Novartis halts ALS drug development after mid-stage trial failure
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
Sektori-
Uebsajtinovartis.com